Laos vs Norway: Previously treated cases tested for RR-/MDR-TB
Laos
100.0%
in 2024
Norway
100.0%
in 2024
Laos rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Laos
- Norway
How they compare
Laos currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 4 times across 13 shared years of data; in 2012 it was Norway ahead.
Laos ranks 1st and Norway ranks 1st of 180 countries.
Across the 2 decades both report, Laos averaged higher in 1 and Norway in 1.
Head to head by decade
| Decade | Laos | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 50.5% | 59.4% | 8.9% | Norway |
| 2020s | 100.0% | 89.4% | 10.6% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Laos or Norway?
- Laos, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Laos and Norway?
- 0.0%, with Laos ahead.
- How many years of comparable data are there for Laos and Norway?
- 13 years are reported by both, from 2012 to 2024.
- How do Laos and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Laos ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.